COVID-19 vaccines – FDA makes recommendations for new monovalent vaccine composition for 2024-2025
June 13, 2024 - The FDA advised that the preferred JN.1-lineage for the COVID-19 vaccines (2024 - 2025 formula) is the KP.2 strain, if feasible.
June 13, 2024 - The FDA advised that the preferred JN.1-lineage for the COVID-19 vaccines (2024 - 2025 formula) is the KP.2 strain, if feasible.